Stemedica International ^Company

Stemedica International is a biotechnology company that specializes in stem cell therapies for degenerative diseases. They were founded in 2008 and have exclusive rights to manufacture and apply stem cell lines for the treatment and prevention of Alzheimer's disease and vascular dementia. Their stem cell lines have a unique technology based on constant hypoxia, which provides benefits in terms of safety, efficacy, and scalability. The company has headquarters in Lausanne, Switzerland, and a U.S. office in San Diego, California.